In one aspect, the invention relates to compounds of formula I:
where Y, R
1
, R
2
, n, and Q are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin reuptake inhibitors. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.
在一个方面,本发明涉及公式I的化合物:其中Y,R1,R2,n和Q如规范中所定义,或其药学上可接受的盐。公式I的化合物是
血清素重摄取
抑制剂。在另一个方面,本发明涉及包括这种化合物的制药组合物;使用这种化合物的方法;以及制备这种化合物的过程和中间体。